229 related articles for article (PubMed ID: 15793119)
1. Susceptibility to antibiotics and beta-lactamase induction in murein hydrolase mutants of Escherichia coli.
Korsak D; Liebscher S; Vollmer W
Antimicrob Agents Chemother; 2005 Apr; 49(4):1404-9. PubMed ID: 15793119
[TBL] [Abstract][Full Text] [Related]
2. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
3. Effects of multiple deletions of murein hydrolases on viability, septum cleavage, and sensitivity to large toxic molecules in Escherichia coli.
Heidrich C; Ursinus A; Berger J; Schwarz H; Höltje JV
J Bacteriol; 2002 Nov; 184(22):6093-9. PubMed ID: 12399477
[TBL] [Abstract][Full Text] [Related]
4. Expression of AmpC beta-lactamase in Enterobacter cloacae isolated from retail ground beef, cattle farm and processing facilities.
Kim SH; Wei CI
J Appl Microbiol; 2007 Aug; 103(2):400-8. PubMed ID: 17650200
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
6. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
7. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
[TBL] [Abstract][Full Text] [Related]
8. [Beta-lactamase synthesis and excretion in a non-leaky wild strain and a leaky mutant of Escherichia coli K-12].
Fognini-Lefebvre N; Portalier R
C R Seances Acad Sci III; 1983 Jan; 296(2):119-22. PubMed ID: 6404516
[TBL] [Abstract][Full Text] [Related]
9. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
Mammeri H; Poirel L; Nordmann P
J Antimicrob Chemother; 2007 Sep; 60(3):490-4. PubMed ID: 17586561
[TBL] [Abstract][Full Text] [Related]
10. Interference with murein turnover has no effect on growth but reduces beta-lactamase induction in Escherichia coli.
Kraft AR; Prabhu J; Ursinus A; Höltje JV
J Bacteriol; 1999 Dec; 181(23):7192-8. PubMed ID: 10572120
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic effect of acridine orange on the expression of penicillin G acylase and beta-lactamase in Escherichia coli.
Arshad R; Farooq S; Iqbal N; Ali SS
Lett Appl Microbiol; 2006 Feb; 42(2):94-101. PubMed ID: 16441371
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
[TBL] [Abstract][Full Text] [Related]
13. Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.
Schmidtke AJ; Hanson ND
Antimicrob Agents Chemother; 2006 Jun; 50(6):2030-7. PubMed ID: 16723562
[TBL] [Abstract][Full Text] [Related]
14. [Expression of high-level cephalosporinase due to mutation in the AmpC attenuator of a clinical Escherichia coli strain].
Guan XZ; Liu YN; Luo YP; She DY; Lu SJ; Zhou G; Chen LA
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):600-4. PubMed ID: 16681904
[TBL] [Abstract][Full Text] [Related]
15. Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae.
Kaneko K; Okamoto R; Nakano R; Kawakami S; Inoue M
J Clin Microbiol; 2005 Jun; 43(6):2955-8. PubMed ID: 15956430
[TBL] [Abstract][Full Text] [Related]
16. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
17. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Tan TY; Ng SY; Teo L; Koh Y; Teok CH
J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
[TBL] [Abstract][Full Text] [Related]
18. [A study on beta-lactamase activity of biofilm Escherichia coli].
He P; Li N; Li S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):537-8. PubMed ID: 11758168
[TBL] [Abstract][Full Text] [Related]
19. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
